Philly Fights Cancer

Knowledge can save lives. Lynch syndrome — an inherited condition that increases the risk of several cancers, including colorectal and endometrial cancers — often goes undiagnosed. Increased awareness, genetic testing, and early screenings can make a life-changing difference for individuals and families. Read this article from HuffPost to learn more:
https://www.huffpost.com/entry/lynch-syndrome-causes-cancer-testing_l_69bd9fd4e4b01c6ce8859662

A new experimental mRNA cancer vaccine is showing promising long-term results in pancreatic cancer research — bringing hope to patients facing one of the deadliest cancers. Presented at the American Association for Cancer Research Annual Meeting, these findings are a powerful reminder of why continued investment in cancer research is so critical.“The entire country has been asking, ‘How valuable is cancer research to our society?’ And what we heard from the public and our patients is, it’s super-important.” — Robert Vonderheide, MD, DPhil, Director of the Abramson Cancer Center and President-Elect of AACR. Read more at the NBC article linked below:https://www.nbcnews.com/health/cancer/pancreatic-cancer-mrna-vaccine-shows-lasting-results-early-trial-rcna331969

Breaking barriers in one of the toughest cancers.

We’re proud to spotlight groundbreaking research from Penn Vet that could transform how we treat pancreatic cancer.

By using lipid nanoparticles to reprogram CAR T cells inside the body, researchers are targeting the support system tumors rely on—effectively “melting away” the protective barrier that has long made solid tumors so difficult to treat.

This innovative approach not only shows promise in slowing tumor growth, but could also lead to safer, more accessible, and more cost-effective therapies—opening the door for CAR T success beyond blood cancers.

Because progress means finding new ways in—especially when the odds are toughest.

Read more via Penn Medicine News: https://penntoday.upenn.edu/news/targeting-tumor-supporting-cells-advancing-car-t-success-pancreatic-cancer